Recent Articles from Chartmill
ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Website: https://www.chartmill.com
TSM stock exemplifies the CAN SLIM strategy with strong earnings growth, market leadership, and solid institutional backing.
Via Chartmill · November 12, 2025
Vericel (VCEL) offers affordable growth in biotech with strong revenue & earnings, solid financials, and a reasonable valuation relative to peers.
Via Chartmill · November 12, 2025
Curious about the S&P500 stocks that are showing activity before the opening bell on Wednesday?
Via Chartmill · November 12, 2025
Genpact (G) is a quality investment with strong profitability, low debt, and consistent growth. Its solid financial health and reasonable valuation make it ideal for long-term investors.
Via Chartmill · November 12, 2025
GLOBALFOUNDRIES Q3 2025 earnings beat EPS estimates with $0.41. Revenue was $1.688B, slightly below forecasts. Strong margins, cash flow, and a solid Q4 outlook highlight disciplined execution.
Via Chartmill · November 12, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · November 12, 2025
Arcos Dorados (ARCO) Q3 2025 earnings beat estimates with a $0.71 EPS, driven by a one-time tax credit, while revenue of $1.19B missed forecasts.
Via Chartmill · November 12, 2025
McGraw Hill (MH) Q2 2026 earnings smash EPS estimates. The company raises its full-year profit guidance on strong digital growth and margin expansion.
Via Chartmill · November 12, 2025
Ovid Therapeutics announces CEO succession plan and key pipeline progress for epilepsy drug OV329 and KCC2 activators, backed by a strong cash position.
Via Chartmill · November 12, 2025
Acumen Pharmaceuticals posts better-than-expected Q3 2025 results, advancing its Alzheimer's treatment pipeline with cash into 2027.
Via Chartmill · November 12, 2025
CorMedix Inc. (CRMD) Q3 2025 earnings show a revenue beat of $104.3M, but an EPS miss. The stock rose in pre-market trading on strong sales growth.
Via Chartmill · November 12, 2025
Innoviz Q3 2025 earnings beat revenue estimates, sees 130% YTD growth, and reaffirms full-year targets, sparking a positive market reaction.
Via Chartmill · November 12, 2025
Humacyte (HUMA) missed Q3 revenue estimates but delivered a smaller-than-expected loss per share. The stock rose as investors focused on its pipeline progress toward key regulatory milestones.
Via Chartmill · November 12, 2025
Perion Network Q3 2025 earnings smash profit estimates, with EPS of $0.28. Revenue grows 8% to $110.5M, driven by a 75% surge in Connected TV.
Via Chartmill · November 12, 2025
Gilat Satellite Networks (GILT) Q3 earnings crush estimates, with EPS nearly doubling forecasts. The strong results sparked a major pre-market rally and prompted raised 2025 guidance.
Via Chartmill · November 12, 2025
Milestone Pharmaceuticals beat Q3 earnings estimates, with a narrower loss. The stock rose as investors await the December 2025 FDA decision for its lead drug, CARDAMYST™.
Via Chartmill · November 12, 2025
Abeona Therapeutics beat Q3 EPS estimates but missed on revenue. The stock fell as investors focus on the delayed launch of its new gene therapy, ZEVASKYN.
Via Chartmill · November 12, 2025
Prelude Therapeutics beats Q3 2025 earnings estimates, extends cash runway into 2027, and advances its precision oncology pipeline.
Via Chartmill · November 12, 2025
Agnico Eagle Mines (AEM) stock shows a powerful mix of strong technical uptrend and accelerating fundamental growth, making it a top pick for momentum investors.
Via Chartmill · November 12, 2025
Caesarstone (CSTE) Q3 2025 results show revenue beat estimates, but earnings missed with a wider loss. The company announced a major restructuring to cut costs.
Via Chartmill · November 12, 2025
IHS Holding Q3 2025 earnings smash expectations, with EPS 300% above estimates. Strong revenue growth and raised full-year guidance fuel an 18% pre-market stock surge.
Via Chartmill · November 12, 2025
Super Micro Computer (SMCI) offers strong growth potential in AI and data centers at a reasonable valuation, making it a top affordable growth stock.
Via Chartmill · November 12, 2025
United Therapeutics (UTHR) offers strong value with a low P/E ratio, zero debt, and high profitability. This biotech stock presents a compelling opportunity for value investors.
Via Chartmill · November 12, 2025
Discover how Shoals Technologies (SHLS) fits the Minervini Trend Template, combining a strong technical uptrend with accelerating earnings and sales growth for high-growth momentum investors.
Via Chartmill · November 12, 2025
Discover Atour Lifestyle (ATAT), a strong growth stock with robust fundamentals and a technical breakout setup signaling a potential upward trend.
Via Chartmill · November 12, 2025
BitFuFu (FUFU) stock surges after Q3 2025 earnings crush estimates. Revenue doubled year-over-year to $180.7M, driving a major profit turnaround.
Via Chartmill · November 12, 2025
On Holding AG (ONON) Q3 2025 earnings smash expectations with a 74% EPS beat and strong sales, leading to a raised 2025 outlook and a major stock surge.
Via Chartmill · November 12, 2025
Discover how Timken Co (TKR) offers a stable dividend with a sustainable payout ratio and strong financials for reliable long-term income.
Via Chartmill · November 12, 2025
Rockwell Medical's Q3 2025 results missed estimates with a 44% revenue decline and wider net loss, driven by a major customer transition.
Via Chartmill · November 12, 2025
Tencent Music (TME) Q3 2025 earnings beat analyst estimates for both revenue and profit, sparking a positive pre-market stock reaction.
Via Chartmill · November 12, 2025
Hippo Holdings (HIPO) aligns with Louis Navellier's growth investing principles, showing massive EPS growth, rising revenue, and improving margins.
Via Chartmill · November 12, 2025
GE stock aligns with the CAN SLIM strategy, showing strong earnings growth, high ROE, and technical momentum, making it a top growth candidate.
Via Chartmill · November 12, 2025
Discover IDAHO STRATEGIC RESOURCES (IDR), a high-growth stock with strong earnings momentum and a positive technical setup for a potential breakout.
Via Chartmill · November 12, 2025
Discover how DHT Holdings aligns with Peter Lynch's investment philosophy. Strong financial health, solid growth, and attractive valuation make it a compelling Lynch-style stock.
Via Chartmill · November 12, 2025
Alphatec Holdings (ATEC) fits Mark Minervini's Trend Template, showing a strong technical uptrend and high-growth fundamentals with accelerating revenue.
Via Chartmill · November 12, 2025
Discover Victory Capital (VCTR), a growth stock with strong fundamentals and a favorable technical setup for a potential breakout, offering value in asset management.
Via Chartmill · November 12, 2025
Vipshop (VIPS) aligns with Peter Lynch's GARP strategy, showing strong EPS growth, a low PEG ratio, and a healthy ROE, making it a compelling value stock.
Via Chartmill · November 12, 2025
McDonald's offers a reliable 2.49% dividend yield, backed by a decade of growth, strong profitability, and solid financial health for income investors.
Via Chartmill · November 12, 2025
KLA Corp (KLAC) combines strong fundamentals with bullish technical patterns. Its exceptional ROIC and profit margins align with a bull flag breakout setup in the semiconductor sector.
Via Chartmill · November 12, 2025
After Monday's strong session, Tuesday’s market breadth remained constructive, though signs of deceleration are emerging. While breadth remains positive overall, participation has narrowed slightly, and follow-through strength was moderate rather than broad-based.
Via Chartmill · November 12, 2025
Brinker International (EAT) excels with 38% EBIT growth, 29% ROIC, and strong cash flow, making it a top pick for quality investors using the Caviar Cruise screening method.
Via Chartmill · November 12, 2025
Travel + Leisure Co (TNL) appears undervalued with strong fundamentals, including a low P/E ratio, solid profitability, a healthy 3.6% dividend yield, and an accelerating growth outlook.
Via Chartmill · November 12, 2025
Vertex Pharmaceuticals offers strong growth, solid profits, and a healthy balance sheet, all at a reasonable valuation compared to its biotech peers.
Via Chartmill · November 12, 2025
Primoris Services (PRIM) identified as a top growth stock with strong earnings, soaring revenue, and accelerating cash flow, fitting a proven investment strategy.
Via Chartmill · November 12, 2025
Discover ESSENT GROUP LTD (ESNT), a value stock with strong financials, low P/E ratios, and high profitability, signaling a potential market undervaluation.
Via Chartmill · November 12, 2025
Salesforce exemplifies quality investing with strong revenue growth, exceptional ROIC, minimal debt, and robust cash flow conversion, per the Caviar Cruise methodology.
Via Chartmill · November 12, 2025
QUALCOMM (QCOM) presents a strong value investing case with attractive valuation metrics, solid financial health, and consistent profitability in the semiconductor sector.
Via Chartmill · November 12, 2025
Discover MINISO (MNSO), a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation for global retail expansion.
Via Chartmill · November 12, 2025
Cummins Inc. (CMI) is a strong dividend stock with steady growth, a sustainable payout ratio, and solid profitability to support long-term income.
Via Chartmill · November 12, 2025
Customers Bancorp (CUBI) stock shows strong technical uptrend momentum and high-growth fundamentals, making it a compelling market leader candidate.
Via Chartmill · November 12, 2025
Optimism about a possible end to the U.S. government shutdown pushed the Dow Jones to new highs, but Big Tech couldn’t keep up. Nvidia took a beating after SoftBank’s surprise exit.
Via Chartmill · November 12, 2025
Hyliion's Q3 2025 results show a revenue miss but a narrower loss. The focus remains on progress with its KARNO generator and a strong cash position.
Via Chartmill · November 11, 2025
Iridex (IRIX) reported mixed Q3 2025 results, missing revenue and EPS estimates. The stock fell over 13% despite highlighting operational improvements and cost reductions.
Via Chartmill · November 11, 2025
Black Rock Coffee Bar's first earnings as a public company show strong revenue growth and store expansion, but a wider GAAP net loss led to a negative market reaction.
Via Chartmill · November 11, 2025
LightPath Technologies (LPTH) beat Q1 2026 revenue estimates by 16%, driving a positive stock surge despite reporting a loss.
Via Chartmill · November 11, 2025
American Integrity Insurance (AII) reported strong Q3 2025 earnings, beating EPS and revenue estimates. The Florida insurer saw robust growth in premiums and a profitable combined ratio.
Via Chartmill · November 11, 2025
Amdocs Q4 2025 earnings met profit forecasts amid a strategic pivot. Revenue slightly missed, but margins expanded and the company projects growth for fiscal 2026.
Via Chartmill · November 11, 2025
Evolution Petroleum (EPM) reports Q1 FY2026 results with a slight revenue miss but maintains its consistent $0.12 dividend payout to shareholders.
Via Chartmill · November 11, 2025
Similarweb's Q3 2025 results show an EPS beat but a revenue miss. The company also raised its full-year profit outlook while providing a conservative revenue forecast.
Via Chartmill · November 11, 2025
Spectral AI (MDAI) Q3 2025 earnings miss analyst estimates as revenue declines and losses widen, prompting a negative market reaction.
Via Chartmill · November 11, 2025
Stereotaxis stock fell sharply after Q3 2025 results, as a 13% revenue miss overshadowed a smaller-than-expected quarterly loss.
Via Chartmill · November 11, 2025
NEXGEL's Q3 2025 results show a revenue miss but a narrower-than-expected loss. The hydrogel firm's mixed earnings prompt a measured market reaction.
Via Chartmill · November 11, 2025
Intrusion Inc. posts Q3 2025 revenue of $2.0M, beating estimates. However, a larger-than-expected loss sends the stock lower in after-hours trading.
Via Chartmill · November 11, 2025
Oklo's Q3 2025 results show a wider-than-expected loss, but the advanced nuclear firm remains focused on long-term regulatory and technology milestones.
Via Chartmill · November 11, 2025
MicroVision's Q3 2025 results show a smaller-than-expected loss but revenue missed estimates. The lidar firm announced new leadership, product launches, and a strategic acquisition.
Via Chartmill · November 11, 2025
Fathom Holdings Q3 2025 earnings beat revenue estimates with 38% YoY growth. The real estate tech firm also reported a second consecutive quarter of adjusted EBITDA profitability.
Via Chartmill · November 11, 2025
Shoulder Innovations (SI) stock surges after a strong Q3 2025 revenue beat and the company raises its full-year sales guidance.
Via Chartmill · November 11, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · November 11, 2025
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · November 11, 2025
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · November 11, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · November 11, 2025
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · November 11, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · November 11, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · November 11, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · November 11, 2025